Walid Abi-Saab
Directeur Technique/Scientifique/R&D chez UNIQURE N.V.
Fortune : 529 818 $ au 30/04/2024
Provenance du réseau au premier degré de Walid Abi-Saab
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
16
| Public Company | Biotechnology | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Walid Abi-Saab via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Public Communications Contact Corporate Officer/Principal | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Mogen International Nv
 Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The private company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
| East Carolina University | College/University | Masters Business Admin | |
| Tufts University | College/University | Graduate Degree | |
| State University of New York at Buffalo | College/University | Graduate Degree | |
| Trinity College Dublin | College/University | Graduate Degree Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree Graduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Consultant / Advisor | |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Analyst-Equity | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| Puerto Rico USA Citizenship Foundation | Corporate Officer/Principal | ||
| STEVANATO GROUP S.P.A. | Medical Specialties | Director/Board Member | |
| Indian Institute of Technology Bombay | College/University | Undergraduate Degree | |
| Molecular Probes Europe BV | Corporate Officer/Principal Chief Executive Officer | ||
| CATALENT, INC. | Pharmaceuticals: Major | Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| MOLECURE S.A. | Pharmaceuticals: Major | Chairman | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Biotechnology | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Information Technology Services | Corporate Officer/Principal | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Chairman | |
| Camping & Education Foundation | Director/Board Member | ||
| Kyowa Kirin, Inc. | Director/Board Member | ||
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Sanofi Pasteur Holding Ltd.
 Sanofi Pasteur Holding Ltd. Financial ConglomeratesFinance Part of Sanofi, Sanofi Pasteur Holding Ltd. functions as an investment holding British company. The private company is based in Guildford, UK. | Financial Conglomerates | Director/Board Member | |
| JFYNetworks, Inc | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 33 |
| Pays-Bas | 5 |
| Belgique | 4 |
| Canada | 4 |
| France | 3 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 144 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 33 |
| Undergraduate Degree | 23 |
Relations les plus connectées
| Insiders | |
|---|---|
| Leonard Post | 25 |
| Jérôme Contamine | 23 |
| Harrold van Barlingen | 20 |
| Daniel O'Day | 19 |
| David Meek | 18 |
| Lena Elisabeth Svanberg | 16 |
| Jacques Suzanne | 15 |
| Madhavan Balachandran | 15 |
| Katrine Bosley | 15 |
| Andre Hoekema | 14 |
| Howard Mitchell Rowe | 14 |
| Jeremy Springhorn | 14 |
| Onno van de Stolpe | 13 |
| Paula Soteropoulos | 13 |
| Paulus Stoffels | 11 |
- Bourse
- Insiders
- Walid Abi-Saab
- Connexions Sociétés
